Safety of intravitreal ziv-aflibercept in choroido-retinal vascular diseases: A randomised double-blind intervention study
Table 2
Ocular and systemic adverse events by treatment group.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Ocular and systemic adverse events by treatment group.